Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience
Michael J. Carr, James Sun, Danielle K. DePalo, et al.
Annals of Surgical Oncology (2021) Vol. 29, Iss. 2, pp. 791-801
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Therapy with oncolytic viruses: progress and challenges
Sophia Z. Shalhout, David M. Miller, Kevin S. Emerick, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 3, pp. 160-177
Closed Access | Times Cited: 282
Oncolytic virus delivery modulated immune responses toward cancer therapy: Challenges and perspectives
Mohsen Keshavarz, Seyed Mohammad Miri, Emad Behboudi, et al.
International Immunopharmacology (2022) Vol. 108, pp. 108882-108882
Open Access | Times Cited: 31
The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases – A multicenter cohort study
Carl Jacob Holmberg, Lars Ny, Tina J. Hieken, et al.
European Journal of Cancer (2022) Vol. 169, pp. 210-222
Open Access | Times Cited: 21
Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical
Chao Tang, Lan Li, Tong Mo, et al.
Clinical & Translational Oncology (2022) Vol. 24, Iss. 9, pp. 1682-1701
Open Access | Times Cited: 17
Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review
Simran Kalsi, Amanda L Galenkamp, Rohit Singh, et al.
Current Oncology Reports (2024)
Open Access | Times Cited: 3
Regional Therapies for Melanoma and Merkel Cell Carcinoma
Adrienne B. Shannon, Jonathan S. Zager
Surgical Clinics of North America (2025)
Closed Access
Advancements in Melanoma Treatment: A Review of PD-1 Inhibitors, T-VEC, mRNA Vaccines, and Tumor-Infiltrating Lymphocyte Therapy in an Evolving Landscape of Immunotherapy
Apoorva Mehta, Mateen Motavaf, Ikenna David Nebo, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1200-1200
Open Access
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies
Lorella Tripodi, Emanuele Sasso, Sara Feola, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1297-1297
Open Access | Times Cited: 8
Intralesional and Infusional Updates for Metastatic Melanoma
Michelle M. Dugan, Adrienne B. Shannon, Danielle K. DePalo, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 1957-1957
Open Access | Times Cited: 3
Advances in the Management of Melanoma
Caitlyn Balsay-Patel, Michelle M. Dugan, Jonathan S. Zager
Surgical Oncology (2024) Vol. 57, pp. 102143-102143
Closed Access | Times Cited: 3
Recombinant Viral Vectors for Therapeutic Programming of Tumour Microenvironment: Advantages and Limitations
Karīna Spunde, Ksenija Korotkaja, Anna Zajakina
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2142-2142
Open Access | Times Cited: 12
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0
Joseph Markowitz, Michael J. Shamblott, Andrew S. Brohl, et al.
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 8, pp. 1139-1143
Open Access | Times Cited: 2
Electrochemotherapy with intravenous bleomycin for patients with cutaneous malignancies, across tumour histology: a systematic review
Freya A. Bastrup, Mille Vissing, Julie Gehl
Acta Oncologica (2022) Vol. 61, Iss. 9, pp. 1093-1104
Open Access | Times Cited: 10
European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanoma
L Campana, Sofia Farronato, Jackie Hodgetts, et al.
British journal of surgery (2023) Vol. 110, Iss. 7, pp. 818-830
Open Access | Times Cited: 4
Treatment strategies with electrochemotherapy for limb in-transit melanoma: real-world outcomes from a European, retrospective, cohort study
L Campana, Francesca Tauceri, Joana Bártolo, et al.
European Journal of Surgical Oncology (2024), pp. 108740-108740
Closed Access | Times Cited: 1
External Validation of a Dutch Predictive Nomogram for Complete Response to T-VEC in an Independent American Patient Cohort
Emma H. A. Stahlie, Michael J. Carr, Jonathan S. Zager, et al.
Annals of Surgical Oncology (2021) Vol. 29, Iss. 3, pp. 1637-1644
Closed Access | Times Cited: 6
Low-Risk Non-mucinous Adenocarcinoma of the Appendix: When Is an Appendectomy Enough?
Kevin M. Turner, Sameer H. Patel
Annals of Surgical Oncology (2022) Vol. 29, Iss. 4, pp. 2144-2145
Open Access | Times Cited: 4
Locoregional melanoma metastases resistant to PD-1 inhibitor therapy treated with intralesional talimogene laherparepvec
Matthew M. Wallace, John A. Zitelli
JAAD Case Reports (2023) Vol. 43, pp. 12-14
Open Access | Times Cited: 2
Talimogene Laherparepvec in Combination with Immunotherapy, A Viable Option?
Jonathan S. Zager, Alexander C.J. van Akkooi
Annals of Surgical Oncology (2022) Vol. 30, Iss. 3, pp. 1279-1281
Open Access | Times Cited: 3
Management of intramuscular melanoma metastases to the psoas
Charles Joseph Cash, Joseph Pearson, Clara Milikowski, et al.
BMJ Case Reports (2024) Vol. 17, Iss. 6, pp. e257500-e257500
Closed Access
Viral Immunotherapy Strategies in Clinical Practice
Jeffrey Johnson, James W. Jakub
Springer eBooks (2024), pp. 57-61
Closed Access
Adjuvant Radiation Therapy in Macroscopic Regional Nodal Melanoma
Gerald Fogarty
Cancers (2024) Vol. 16, Iss. 23, pp. 3950-3950
Open Access
Real-world outcomes with T-VEC in patients with anti-PD-1 resistant in-transit disease from melanoma and Merkel cell carcinoma
David Su, Madeline McNamara, Margaret A. Kaszycki, et al.
Surgical Oncology Insight (2024), pp. 100120-100120
Open Access
Oncolytic intralesional therapy for metastatic melanoma
Danielle K. DePalo, Matthew Perez, Anne Huibers, et al.
Clinical & Experimental Metastasis (2023) Vol. 41, Iss. 4, pp. 457-460
Closed Access | Times Cited: 1
Management of In-Transit Metastatic Melanoma
Matthew Perez, Jonathan S. Zager
Advances in Oncology (2023) Vol. 3, Iss. 1, pp. 29-36
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top